The RGSZ2 protein exists in a complex with μ-opioid receptors and regulates the desensitizing capacity of Gz proteins

Neuropsychopharmacology

Volumn 30, Issue 9, 2005, Pages 1632-1648

  Garzón, Javier ^a,b   Rodríguez Muñoz, María ^a   López Fando, Almudena ^a   Sánchez Blázquez, Pilar ^a  

^a CSIC   (Spain)

^b INSTITUTO CAJAL   (Spain)

Author keywords

Antisense technology; Desensitization; G protein signaling; Mu opioid receptor; RGSZ2

Indexed keywords

ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MORPHINE; MU OPIATE RECEPTOR; PROTEIN; PROTEIN RGSZ2; UNCLASSIFIED DRUG; ANTISENSE OLIGODEOXYNUCLEOTIDE; GNAZ PROTEIN, MOUSE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; MESSENGER RNA; NARCOTIC AGENT; NARCOTIC ANALGESIC AGENT; RGS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DESENSITIZATION; DRUG POTENTIATION; GLYCOSYLATION; HYPOTHALAMUS; MALE; MOUSE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL BEHAVIOR; BIOLOGICAL MODEL; BIOSYNTHESIS; CHEMISTRY; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INTERACTION; DRUG TOLERANCE; GENE EXPRESSION REGULATION; GENETICS; HISTOLOGY; IMMUNOLOGY; IMMUNOPRECIPITATION; METABOLISM; METHODOLOGY; MOUSE MUTANT; NORTHERN BLOTTING; PAIN ASSESSMENT; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNAPTOSOME; TIME; WESTERN BLOTTING;

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, NORTHERN; BLOTTING, WESTERN; CENTRAL NERVOUS SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG TOLERANCE; GENE EXPRESSION REGULATION; GLYCOSYLATION; GTP-BINDING PROTEIN ALPHA SUBUNITS; GTP-BINDING PROTEINS; IMMUNOPRECIPITATION; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MORPHINE; NARCOTICS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PAIN MEASUREMENT; RECEPTORS, OPIOID, MU; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RGS PROTEINS; RNA, MESSENGER; SYNAPTOSOMES; TIME FACTORS;

EID: 27744598288     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300726     Document Type: Article

References (61)

1. Anger T, Zhang W, Mende U (2004). Differential contribution of GTPase activation and effector antagonism to the inhibitory effect of RGS proteins on Gq-mediated signaling in vivo. J Biol Chem 279: 3906-3915.
2. Berman DM, Kozasa T, Gilman AG (1996). The GTPase-activating protein RGS4 stabilizes the transition state for nucleotide hydrolysis. J Biol Chem 271: 27209-27212.
3. Bernstein LS, Ramineni S, Hague C, Cladman W, Chidiac P, Levey AI et al (2004). RGS2 binds directly and selectively to the M1 muscarinic acetylcholine receptor third intracellular loop to modulate Gq/11α signaling. J Biol Chem 279: 21248-21256.
4. Carman CV, Parent J-L, Day PW, Pronin AN, Sternweis PM, Wedegaertner PB et al (1999). Selective regulation of Gαq/11 by an RGS domain in the G protein-coupled receptor kinase, GRK2. J Biol Chem 274: 34483-34492.
5. Carrasco GA, Barker SA, Zhang Y, Damjanoska KJ, Sullivan NR, Garcia F et al (2004). Estrogen treatment increases the levels of regulator of G protein signaling-Z1 in the hypothalamic paraventricular nucleus: possible role in desensitization of 5-hydroxytryptamine 1A receptors. Neuroscience 127: 261-267.
6. Casey PJ, Fong HKW, Simon MI, Gilman AG (1990). Gz, a guanine nucleotide-binding protein with unique biochemical properties. J Biol Chem 265: 2383-2390.
7. Chatterjee TK, Eapen AK, Fisher RA (1997). A truncated form of RGS3 negatively regulates G protein coupled receptor stimulation of adenylyl cyclase and phosphoinositide phospholipase C. J Biol Chem 272: 15481-15487.
8. De Vries L, Elenko E, Hubler L, Jones TL, Farquhar MG (1996). GAIP is membrane-anchored by palmitoylation and interacts with the activated (GTP-bound) form of Gαi subunits. Proc Natl Acad. Sci USA 93: 15203-15208.
9. De Vries L, Lou X, Zhao G, Zheng B, Farquhar MG (1998). GIPC, a PDZ domain containing protein, interacts specifically with the C terminus of RGS-GAIP. Proc Natl Acad Sci USA 95: 12340-12345.
10. De Vries L, Mousli M, Wurmser A, Farquhar MG (1995). GAIP, a protein that specifically interacts with the trimeric G protein Gαi3, is a member of a protein family with a highly conserved core domain. Proc Natl Acad. Sci USA 92: 11916-11920.
11. Fischer T, De vries L, Meerlo T, Farquhar MG (2003). Promotion of Gαi3 subunit down-regulation by GIPN, a putative E3 ubiquitin lugase that interacts with RGS-GAIP. Proc Natl Acad Sci USA 100: 8270-8275.
12. Fischer T, Elenko E, Wan L, Thomas G, Farquhar MG (2000). Membrane-associated GAIP is a phosphoprotein and can be phosphorylated by clathrin-coated vesicles. Proc Natl Acad Sci USA 97: 4040-4045.
13. Fong HK, Yoshimoto KK, Eversole-Cire P, Simon MI (1988). Identification of a GTP-binding protein α subunit that lacks an apparent ADP-ribosylation site for pertussis toxin. Proc Natl Acad Sci USA 85: 3066-3070.
14. Garzón J, De Antonio I, Sánchez-Blázquez P (2000). In vivo modulation of G proteins and opioid receptor function by antisense oligodeoxynucleotides. Methods Enzymol 314: 3-20.
15. Garzón J, García-España A, Sánchez- Blázquez P (1997a). Opioids binding mu and delta receptors exhibit diverse efficacy in the activation of Gi2 and Gx/z transducer proteins in mouse periaqueductal gray matter. J Pharmacol Exp Ther 281: 549-557.
16. Garzón J, Juarros JL, Castro MA, Sánchez-Blázquez P (1995). Antibodies to the cloned μ-opioid receptor detect various molecular weight forms in areas of mouse brain. Mol Pharmacol 47: 738-744.
17. Garzón J, López-Fando A, Sánchez-Blázquez P (2003). The R7 subfamily of RGS proteins assists tachyphylaxis and acute tolerance at μ-opioid receptors. Neuropsychopharmacology 28: 1983-1990.
18. Garzón J, Martínez-Peña Y, Sánchez- Blázquez P (1997b). Gx/z is regulated by μ but not δ opioid receptors in the stimulation of the low Km GTPase activity in mouse periaqueductal grey matter. Eur J Neurosci 9: 1194-1200.
19. Garzón J, Rodríguez-Díaz M, López-Fando A, García-España A, Sánchez-Blázquez P (2002). Glycosylated phosducin-like protein long regulates opioid receptor function in mouse brain. Neuropharmacology 42: 813-828.
20. Garzón J, Rodríguez-Muñoz M, López-Fando A, García-España A, Sánchez-Blázquez P (2004). RGSZ1 and GAIP regulate μ- but not δ-opioid receptors in mouse CNS: role in tachyphylaxis and acute tolerance. Neuropsychopharmacology 29: 1091-1104.
21. Garzón J, Rodríguez-Díaz M, López-Fando A, Sánchez-Blázquez P (2001). RGS9 proteins facilitate acute tolerance to mu-opioid effects. Eur J Neurosci 13: 801-811.
22. Garzón J, Rodríguez-Muñoz M, López-Fando A, Sánchez-Blázquez P (2005). Activation of mu-opioid receptors transfer control of Gα subunits to the regulator of G-protein signaling RGS9-2. Role in receptor desensitization. J Biol Chem 280: 8951-8960.
23. Glick JL, Meigs TE, Miron A, Casey PJ (1998). RGSZ1, a Gz-selective regulator of G protein signaling whose action is sensitive to the phosphorylation state of Gzα. J Biol Chem 273: 26008-26013.
24. 2+ on the guanine nucleotide exchange rate of p21N-ras. J Biol Chem 261: 10963-10965.
25. Hallak H, Muszbek L, Laposata M, Belmonte E, Brass LF, Manning DR (1994). Covalent binding of arachidonate to G protein alpha subunits of human platelets. J Biol Chem 269: 4713-4716.
26. Hepler JR, Berman DM, Gilman AG, Kozasa T (1997). RGS4 and GAIP are GTPase-activating proteins for Gqα and block activation of phospholipase Cβ by γ-thio-GTP-Gqα. Proc Natl Acad Sci USA 94: 428-432.
27. Hinton DR, Blanks JC, Fong HK, Casey PJ, Hildebrandt E, Simons MI (1990). Novel localization of a G protein, Gαz, in neurons of brain and retina. J Neurosci 10: 2763-2770.
28. Ho MK, Chang JS, Yung LY, Wong YH (2000). The effect of protein kinase C activation on Gz-mediated regulation of type 2 and type 6 adenylyl cyclases. Biol Signal Recept 9: 21-28.
29. Huidobro F, Huidobro-Toro JP, Way EL (1976). Studies on tolerance development to single doses of morphine in mice. J Pharmacol Exp Ther 198: 318-326.
30. Hunt TW, Fields TA, Casey PJ, Peralta EG (1996). RGS10 is a selective activator of Gαi GTPase activity. Nature 383: 175-177.
31. Ito E, Xie G, Maruyama K, Palmer PP (2000). A core-promoter region functions bi-directionally for human opioid-receptor-like gene ORL1 and its 5′-adjacent gene GAIP. J Mol Biol 304: 259-270.
32. Jeong SW, Ikeda SR (1998). G protein α subunit Gαz couples neurotransmitter receptors to ion channels in sympathetic neurons. Neuron 21: 1201-1212.
33. Jordan JD, Carey KD, Stork PJS, Iyengar R (1999). Modulation of Rap activity by direct interaction of Gαo with Rap1 GTPase-activating protein. J Biol Chem 274: 21507-21510.
34. Kohno M, Fukushima N, Yoshida A, Ueda H (2000). Gi1 and GoA differentially determine kinetic efficacies of agonists for κ-opioid receptor. FEBS Lett 473: 101-105.
35. Levis MJ, Bourne HR (1992). Activation of the α subunit of Gs in intact cells alters its abundance, rate of degradation, and membrane avidity. J Cell Biol 119: 1297-1307.
36. Lounsbury KM, Casey PJ, Brass LF, Manning DR (1991). Phosphorylation of Gz in human platelets. Selectivity and site of modification. J Biol Chem 266: 22051-22056.
37. Mao H, Zhao Q, Daigle M, Ghahremani MH, Chidiac P, Albert PR (2004). RGS17/RGSZ2, a novel regulator of Gi/o, Gz and Gq signaling. J Biol Chem 279: 26314-26322.
38. Mumby SM, Heukeroth RO, Gordon JI, Gilman AG (1990). G-protein alpha-subunit expression, myristoylation, and membrane association in COS cells. Proc Natl Acad Sci USA 87: 728-732.
39. Ogier-Denis E, Pattingre S, El Benna J, Codogno P (2000). Erk1/2-dependent phosphorylation of Gα-interacting protein stimulates its GTPase accelerating activity and autophagy in human colon cancer cells. J Biol Chem 275: 39090-39095.
40. Posner BA, Gilman AG, Harris BA (1999). Regulators of G protein signaling 6 and 7. Purification of complexes with Gβ5 and assessment of their effects on G protein-mediated signaling pathways. J Biol Chem 274: 31087-31093.
41. Ross EM, Wilkie TM (2000). GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Ann Rev Biochem 69: 795-827.
42. Roy AN, Lemberg KE, Chidiac P (2003). Recruitment of RGS2 and RGS4 to the plasma membrane by G proteins and receptors reflects functional interactions. Mol Pharmacol 64: 587-593.
43. Saitoh O, Murata Y, Osagiri M, Itoh M, Itoh H, Misaka T et al (2002). Alternative splicing of RGS8 gene determines inhibitory function of receptor type-specific Gq signaling. Proc Natl Acad Sci USA 99: 10138-10143.
44. Sánchez-Blázquez P, García-España A, Garzón J (1995). In vivo injection of antisense oligodeoxynucleotides to Gα subunits and supraspinal analgesia evoked by mu and delta opioid agonists. J Pharmacol Exp Ther 275: 1590-1596.
45. Sánchez-Blázquez P, Gómez-Serranillos P, Garzón J (2001). Agonists determine the pattern of G-protein activation in μ-opioid receptor-mediated supraspinal analgesia. Brain Res Bull 54: 229-235.
46. Sánchez-Blázquez P, Rodríguez-Díaz M, De Antonio I, Garzón J (1999). Endomorphin-1 and endomorphin-2 show differences in their activation of μ opioid receptor-regulated G proteins in supraspinal antinociception in mice. J Pharmacol Exp Ther 291: 12-18.
47. Sánchez-Blázquez P, Rodríguez-Díaz M, López-Fando A, Rodríguez-Muñoz M, Garzón J (2003). The GBeta5 subunit that associates with the R7 subfamily of RGS proteins regulates mu-opioid effects. Neuropharmacology 45: 85-98.
48. Sánchez-Blázquez P, Rodríguez-Muñoz M, Montero C, Garzón J (2005). RGS-Rz and RGS9-2 proteins control mu-opioid receptor desensitization in CNS: the role of activated Gαz subunits. Neuropharmacology 48: 134-150.
49. Sierra DA, Gilbert DJ, Householder D, Grishin NV, Yu K, Ukidwe P et al (2002). Evolution of the regulators of G-protein signaling multigene family in mouse and human. Genomics 79: 177-185.
50. Sinnarajah S, Dessauer CW, Srikumar D, Chen J, Yuen J, Yilma S et al (2001). RGS2 regulates signal transduction in olfactory neurons by attenuating activation of adenylyl cyclase III. Nature 409: 1051-1055.
51. Standifer KM, Rossi GC, Pasternak GW (1996). Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein α subunits. Mol Pharmacol 50: 293-298.
52. Tesmer JJ, Berman DM, Gilman AG, Sprang SR (1997). Structure of RGS4 bound to A1F4-activated Giα1: stabilization of the transition state for GTP hydrolysis. Cell 89: 251-261.
53. Tu Y, Wang J, Ross Em (1997). Inhibition of brain Gz GAP and other RGS proteins by palmitoylation of G protein α subunits. Science 278: 1132-1135.
54. Wang J, Ducret A, Tu Y, Kozasa T, Aebersold R, Ross EM (1998). RGSZ1, a Gz-selective RGS protein in brain. J Biol Chem 273: 26014-26025.
55. Wang J, Tu Y, Woodson J, Song X, Ross EM (1997). A GTPase-activating protein for the G protein Gαz. J Biol Chem 272: 5732-5740.
56. Wang Q, Liu M, Mullah B, Siderovski DP, Neubig RR (2002). Receptor-selective effects of endogenous RGS3 and RGS5 to regulate mitogen-activated protein kinase activation in rat vascular muscle cells. J Biol Chem 277: 24949-24958.
57. Wise A, Lee TW, McEwan DJ, Milligan G (1995). Degradation of G11α/Gqα is accelerated by agonist occupancy of α1A/D, α1B, and α1C adrenergic receptors. J Biol Chem 270: 17196-17203.
58. Wong YH, Conklin BR, Bourne HR (1992). Gz-mediated hormonal inhibition of cyclic AMP accumulation. Science 255: 339-342.
59. Xu X, Zeng W, Popov S, Berman DM, Davignon I, Yu K et al (1999). RGS proteins determine signaling specificity of Gq-coupled receptors. J Biol Chem 274: 3549-3556.
60. Yaksh TL, Yeung JC, Rudy TA (1976). Systematic examination in the rat of brain sites sensitive to the direct application of morphine: observation of differential effects within the peria-queductal grey. Brain Res 114: 83-103.
61. Zaworski PG, Alberts GL, Pregenzer JF, Im WB, Slightom JL, Gill GS (1999). Efficient functional coupling of the human D3 dopamine receptor to Go subtype of G proteins in SH-SY5Y cells. Br J Pharmacol 128: 1181-1188.